These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 21134749
21. 5-Piperazinyl-3-sulfonylindazoles as potent and selective 5-hydroxytryptamine-6 antagonists. Liu KG, Robichaud AJ, Bernotas RC, Yan Y, Lo JR, Zhang MY, Hughes ZA, Huselton C, Zhang GM, Zhang JY, Kowal DM, Smith DL, Schechter LE, Comery TA. J Med Chem; 2010 Nov 11; 53(21):7639-46. PubMed ID: 20932009 [Abstract] [Full Text] [Related]
22. Novel 1-(azacyclyl)-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines as 5-HT6 agonists and antagonists. Elokdah H, Li D, McFarlane G, Bernotas RC, Robichaud AJ, Magolda RL, Zhang GM, Smith D, Schechter LE. Bioorg Med Chem; 2007 Sep 15; 15(18):6208-26. PubMed ID: 17624788 [Abstract] [Full Text] [Related]
23. N1-arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonists. Cole DC, Ellingboe JW, Lennox WJ, Mazandarani H, Smith DL, Stock JR, Zhang G, Zhou P, Schechter LE. Bioorg Med Chem Lett; 2005 Jan 17; 15(2):379-83. PubMed ID: 15603958 [Abstract] [Full Text] [Related]
24. Synthesis and in vivo evaluation of [O-methyl-11C] N-[3,5-dichloro-2-(methoxy)phenyl]-4-(methoxy)-3-(1-piperazinyl)benzenesulfonamide as an imaging probe for 5-HT6 receptors. Liu F, Majo VJ, Prabhakaran J, Milak MS, John Mann J, Parsey RV, Kumar JS. Bioorg Med Chem; 2011 Sep 01; 19(17):5255-9. PubMed ID: 21821420 [Abstract] [Full Text] [Related]
25. 1-(Arylsulfonyl)-2,3-dihydro-1H-quinolin-4-one derivatives as 5-HT(6) serotonin receptor ligands. Park CM, Choi JI, Choi JH, Kim SY, Park WK, Seong CM. Bioorg Med Chem Lett; 2011 Jan 15; 21(2):698-703. PubMed ID: 21190848 [Abstract] [Full Text] [Related]
26. Synthesis, 5-HT1A and 5-HT2A receptor activity of new 1-phenylpiperazinylpropyl derivatives with arylalkyl substituents in position 7 of purine-2,6-dione. Chloń G, Pawłowski M, Duszyńska B, Szaro A, Tatarczńska E, Kłodzińska AL, Chojnacka-Wójcik E. Pol J Pharmacol; 2001 Jan 15; 53(4):359-68. PubMed ID: 11990082 [Abstract] [Full Text] [Related]
27. New 1-arylindoles based serotonin 5-HT7 antagonists. Synthesis and binding evaluation studies. Sagnes C, Fournet G, Satala G, Bojarski AJ, Joseph B. Eur J Med Chem; 2014 Mar 21; 75():159-68. PubMed ID: 24531229 [Abstract] [Full Text] [Related]
28. Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents. Leopoldo M, Berardi F, Colabufo NA, Contino M, Lacivita E, Niso M, Perrone R, Tortorella V. J Med Chem; 2004 Dec 16; 47(26):6616-24. PubMed ID: 15588097 [Abstract] [Full Text] [Related]
29. N'-(arylsulfonyl)pyrazoline-1-carboxamidines as novel, neutral 5-hydroxytryptamine 6 receptor (5-HT₆R) antagonists with unique structural features. van Loevezijn A, Venhorst J, Iwema Bakker WI, de Korte CG, de Looff W, Verhoog S, van Wees JW, van Hoeve M, van de Woestijne RP, van der Neut MA, Borst AJ, van Dongen MJ, de Bruin NM, Keizer HG, Kruse CG. J Med Chem; 2011 Oct 27; 54(20):7030-54. PubMed ID: 21866910 [Abstract] [Full Text] [Related]
30. Design, synthesis, and pharmacological evaluation of piperidin-4-yl amino aryl sulfonamides: novel, potent, selective, orally active, and brain penetrant 5-HT₆ receptor antagonists. Nirogi R, Shinde A, Daulatabad A, Kambhampati R, Gudla P, Shaik M, Gampa M, Balasubramaniam S, Gangadasari P, Reballi V, Badange R, Bojja K, Subramanian R, Bhyrapuneni G, Muddana N, Jayarajan P. J Med Chem; 2012 Nov 08; 55(21):9255-69. PubMed ID: 23006002 [Abstract] [Full Text] [Related]
31. Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity. Medina RA, Sallander J, Benhamú B, Porras E, Campillo M, Pardo L, López-Rodríguez ML. J Med Chem; 2009 Apr 23; 52(8):2384-92. PubMed ID: 19326916 [Abstract] [Full Text] [Related]
32. Discovery of 5-HT6 receptor ligands based on virtual HTS. Tasler S, Kraus J, Wuzik A, Müller O, Aschenbrenner A, Cubero E, Pascual R, Quintana-Ruiz JR, Dordal A, Mercè R, Codony X. Bioorg Med Chem Lett; 2007 Nov 15; 17(22):6224-9. PubMed ID: 17892934 [Abstract] [Full Text] [Related]
33. Discovery of 5-arylsulfonamido-3-(pyrrolidin-2-ylmethyl)-1H-indole derivatives as potent, selective 5-HT6 receptor agonists and antagonists. Cole DC, Lennox WJ, Lombardi S, Ellingboe JW, Bernotas RC, Tawa GJ, Mazandarani H, Smith DL, Zhang G, Coupet J, Schechter LE. J Med Chem; 2005 Jan 27; 48(2):353-6. PubMed ID: 15658848 [Abstract] [Full Text] [Related]
34. Investigations on the 1-(2-biphenyl)piperazine motif: identification of new potent and selective ligands for the serotonin(7) (5-HT(7)) receptor with agonist or antagonist action in vitro or ex vivo. Lacivita E, Patarnello D, Stroth N, Caroli A, Niso M, Contino M, De Giorgio P, Di Pilato P, Colabufo NA, Berardi F, Perrone R, Svenningsson P, Hedlund PB, Leopoldo M. J Med Chem; 2012 Jul 26; 55(14):6375-80. PubMed ID: 22738316 [Abstract] [Full Text] [Related]
35. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents. Campiani G, Butini S, Fattorusso C, Catalanotti B, Gemma S, Nacci V, Morelli E, Cagnotto A, Mereghetti I, Mennini T, Carli M, Minetti P, Di Cesare MA, Mastroianni D, Scafetta N, Galletti B, Stasi MA, Castorina M, Pacifici L, Vertechy M, Di Serio S, Ghirardi O, Tinti O, Carminati P. J Med Chem; 2004 Jan 01; 47(1):143-57. PubMed ID: 14695828 [Abstract] [Full Text] [Related]
36. Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N₁-arylsulfonyl indole derivatives as 5-HT₆ receptor ligands. Nirogi RV, Badange R, Kambhampati R, Chindhe A, Deshpande AD, Tiriveedhi V, Kandikere V, Muddana N, Abraham R, Khagga M. Bioorg Med Chem Lett; 2012 Dec 15; 22(24):7431-5. PubMed ID: 23141912 [Abstract] [Full Text] [Related]
37. Novel quinazolinone derivatives as 5-HT7 receptor ligands. Na YH, Hong SH, Lee JH, Park WK, Baek DJ, Koh HY, Cho YS, Choo H, Pae AN. Bioorg Med Chem; 2008 Mar 01; 16(5):2570-8. PubMed ID: 18083580 [Abstract] [Full Text] [Related]
38. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics. Bojarski AJ, Paluchowska MH, Duszyńska B, Kłodzińska A, Tatarczyńska E, Chojnacka-Wójcik E. Bioorg Med Chem; 2005 Mar 15; 13(6):2293-303. PubMed ID: 15727878 [Abstract] [Full Text] [Related]
39. Benzimidazole derivatives. Part 5: design and synthesis of new benzimidazole-arylpiperazine derivatives acting as mixed 5-HT1A/5-HT3 ligands. López-Rodríguez ML, Benhamú B, Morcillo MJ, Tejada I, Avila D, Marco I, Schiapparelli L, Frechilla D, Del Río J. Bioorg Med Chem; 2004 Oct 01; 12(19):5181-91. PubMed ID: 15351401 [Abstract] [Full Text] [Related]
40. New selective and potent 5-HT(1B/1D) antagonists: chemistry and pharmacological evaluation of N-piperazinylphenyl biphenylcarboxamides and biphenylsulfonamides. Liao Y, Böttcher H, Harting J, Greiner H, van Amsterdam C, Cremers T, Sundell S, März J, Rautenberg W, Wikström H. J Med Chem; 2000 Feb 10; 43(3):517-25. PubMed ID: 10669578 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]